Erythropoietin (EPO) Market Report

China Erythropoietin (EPO) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：226
  • REPORT CODE：GMM1806598
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Erythropoietin (EPO) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • LG Life Sciences Ltd

    • Roche

    • Amgen

    • DRG International, Inc

    • Hospira Inc

    • Biocon

    By Type:

    • Epoetin-alfa

    • Others

    • Darbepoetin-alfa

    • Epoetin-beta

    By Application:

    • Renal Diseases

    • Cancer

    • Hematology

    • Neurology

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Erythropoietin (EPO) Market Overview 2018-2029

    • 1.1 China Erythropoietin (EPO) Industry Development Overview

    • 1.2 China Erythropoietin (EPO) Industry Development History

    • 1.3 China Erythropoietin (EPO) Industry Market Size (2018-2029)

    • 1.4 China Erythropoietin (EPO) Market Analysis by Type from Production Side

      • 1.4.1 China Erythropoietin (EPO) Production Volume, Production Value and Growth Rate of Epoetin-alfa (2018-2029)

      • 1.4.2 China Erythropoietin (EPO) Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Erythropoietin (EPO) Production Volume, Production Value and Growth Rate of Darbepoetin-alfa (2018-2029)

      • 1.4.4 China Erythropoietin (EPO) Production Volume, Production Value and Growth Rate of Epoetin-beta (2018-2029)

    • 1.5 China Erythropoietin (EPO) Market Analysis by Application from Consumption End

      • 1.5.1 China Erythropoietin (EPO) Sales Volume, Sales Value and Growth Rate of Renal Diseases (2018-2029)

      • 1.5.2 China Erythropoietin (EPO) Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

      • 1.5.3 China Erythropoietin (EPO) Sales Volume, Sales Value and Growth Rate of Hematology (2018-2029)

      • 1.5.4 China Erythropoietin (EPO) Sales Volume, Sales Value and Growth Rate of Neurology (2018-2029)

    • 1.6 China Erythropoietin (EPO) Market Analysis by Region

      • 1.6.1 North China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Erythropoietin (EPO) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Erythropoietin (EPO) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Erythropoietin (EPO) Market Status and Competition Analysis in 2023

      • 2.2.3 China Erythropoietin (EPO) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Erythropoietin (EPO) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Erythropoietin (EPO) Industry Development

    Chapter 3 Erythropoietin (EPO)Industry Chain Analysis

    • 3.1 Erythropoietin (EPO) Industry Chain

    • 3.2 Erythropoietin (EPO) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Erythropoietin (EPO) Market

    • 3.3 Erythropoietin (EPO) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Erythropoietin (EPO) Market

    Chapter 4 China Erythropoietin (EPO) Market, by Type

    • 4.1 China Erythropoietin (EPO) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Erythropoietin (EPO) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Erythropoietin (EPO) Production Volume and Growth Rate, by Type

      • 4.5.1 China Erythropoietin (EPO) Production Volume and Growth Rate of Epoetin-alfa

      • 4.5.2 China Erythropoietin (EPO) Production Volume and Growth Rate of Others

      • 4.5.3 China Erythropoietin (EPO) Production Volume and Growth Rate of Darbepoetin-alfa

      • 4.5.4 China Erythropoietin (EPO) Production Volume and Growth Rate of Epoetin-beta

    Chapter 5 China Erythropoietin (EPO) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Erythropoietin (EPO) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Erythropoietin (EPO) Market Size and Growth Rate, by Application

      • 5.5.1 China Erythropoietin (EPO) Market Size and Growth Rate of Renal Diseases

      • 5.5.2 China Erythropoietin (EPO) Market Size and Growth Rate of Cancer

      • 5.5.3 China Erythropoietin (EPO) Market Size and Growth Rate of Hematology

      • 5.5.4 China Erythropoietin (EPO) Market Size and Growth Rate of Neurology

    Chapter 6 China Erythropoietin (EPO) Market, by Region

    • 6.1 China Erythropoietin (EPO) Production Volume and Production Value, by Region

    • 6.2 China Erythropoietin (EPO) Sales Volume and Sales Value, by Region

    Chapter 7 North China Erythropoietin (EPO) Market Analysis

    • 7.1 North China Erythropoietin (EPO) Market, by Type

    • 7.2 North China Erythropoietin (EPO) Market, by Application

    Chapter 8 Central China Erythropoietin (EPO) Market Analysis

    • 8.1 Central China Erythropoietin (EPO) Market, by Type

    • 8.2 Central China Erythropoietin (EPO) Market, by Application

    Chapter 9 South China Erythropoietin (EPO) Market Analysis

    • 9.1 South China Erythropoietin (EPO) Market, by Type

    • 9.2 South China Erythropoietin (EPO) Market, by Application

    Chapter 10 East China Erythropoietin (EPO) Market Analysis

    • 10.1 East China Erythropoietin (EPO) Market, by Type

    • 10.2 East China Erythropoietin (EPO) Market, by Application

    Chapter 11 Northeast China Erythropoietin (EPO) Market Analysis

    • 11.1 Northeast China Erythropoietin (EPO) Market, by Type

    • 11.2 Northeast China Erythropoietin (EPO) Market, by Application

    Chapter 12 Southwest China Erythropoietin (EPO) Market Analysis

    • 12.1 Southwest China Erythropoietin (EPO) Market, by Type

    • 12.2 Southwest China Erythropoietin (EPO) Market, by Application

    Chapter 13 Northwest China Erythropoietin (EPO) Market Analysis

    • 13.1 Northwest China Erythropoietin (EPO) Market, by Type

    • 13.2 Northwest China Erythropoietin (EPO) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 LG Life Sciences Ltd

        • 14.1.1 LG Life Sciences Ltd Company Profile

        • 14.1.2 LG Life Sciences Ltd Erythropoietin (EPO) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Roche

        • 14.2.1 Roche Company Profile

        • 14.2.2 Roche Erythropoietin (EPO) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Amgen

        • 14.3.1 Amgen Company Profile

        • 14.3.2 Amgen Erythropoietin (EPO) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 DRG International, Inc

        • 14.4.1 DRG International, Inc Company Profile

        • 14.4.2 DRG International, Inc Erythropoietin (EPO) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Hospira Inc

        • 14.5.1 Hospira Inc Company Profile

        • 14.5.2 Hospira Inc Erythropoietin (EPO) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Biocon

        • 14.6.1 Biocon Company Profile

        • 14.6.2 Biocon Erythropoietin (EPO) Market Performance

        • 14.6.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Erythropoietin (EPO) Industry Research Conclusions

    • 15.2 Erythropoietin (EPO) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Erythropoietin (EPO) Industry Market Size (2018-2029)

    • Figure China Erythropoietin (EPO) Production Volume, Production Value and Growth Rate of Epoetin-alfa (2018-2029)

    • Figure China Erythropoietin (EPO) Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Erythropoietin (EPO) Production Volume, Production Value and Growth Rate of Darbepoetin-alfa (2018-2029)

    • Figure China Erythropoietin (EPO) Production Volume, Production Value and Growth Rate of Epoetin-beta (2018-2029)

    • Figure China Erythropoietin (EPO) Sales Volume, Sales Value and Growth Rate of Renal Diseases (2018-2029)

    • Figure China Erythropoietin (EPO) Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • Figure China Erythropoietin (EPO) Sales Volume, Sales Value and Growth Rate of Hematology (2018-2029)

    • Figure China Erythropoietin (EPO) Sales Volume, Sales Value and Growth Rate of Neurology (2018-2029)

    • Figure North China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

    • Figure Central China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

    • Figure South China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

    • Figure East China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Erythropoietin (EPO) Market Size and Growth Rate from 2018-2029

    • Figure Erythropoietin (EPO) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Erythropoietin (EPO) Market Share by Type in 2018

    • Figure China Erythropoietin (EPO) Market Share by Type in 2023

    • Figure China Erythropoietin (EPO) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Erythropoietin (EPO) Production Volume and Growth Rate of Epoetin-alfa (2018-2023)

    • Figure China Erythropoietin (EPO) Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Erythropoietin (EPO) Production Volume and Growth Rate of Darbepoetin-alfa (2018-2023)

    • Figure China Erythropoietin (EPO) Production Volume and Growth Rate of Epoetin-beta (2018-2023)

    • Figure China Erythropoietin (EPO) Market Share by Application in 2018

    • Figure China Erythropoietin (EPO) Market Share by Application in 2023

    • Figure China Erythropoietin (EPO) Total Market Size and Growth Rate from Consumption End

    • Figure China Erythropoietin (EPO) Market Size and Growth Rate of Renal Diseases (2018-2023)

    • Figure China Erythropoietin (EPO) Market Size and Growth Rate of Cancer (2018-2023)

    • Figure China Erythropoietin (EPO) Market Size and Growth Rate of Hematology (2018-2023)

    • Figure China Erythropoietin (EPO) Market Size and Growth Rate of Neurology (2018-2023)

    • Table China Erythropoietin (EPO) Production Volume by Region (2018-2023)

    • Table China Erythropoietin (EPO) Production Volume Share by Region (2018-2023)

    • Figure China Erythropoietin (EPO) Production Volume Share by Region (2018-2023)

    • Table China Erythropoietin (EPO) Production Value by Region (2018-2023)

    • Table China Erythropoietin (EPO) Production Value Share by Region (2018-2023)

    • Figure China Erythropoietin (EPO) Production Value Share by Region (2018-2023)

    • Table China Erythropoietin (EPO) Sales Volume by Region (2018-2023)

    • Table China Erythropoietin (EPO) Sales Volume Share by Region (2018-2023)

    • Figure China Erythropoietin (EPO) Sales Volume Share by Region (2018-2023)

    • Table China Erythropoietin (EPO) Sales Value by Region (2018-2023)

    • Table China Erythropoietin (EPO) Sales Value Share by Region (2018-2023)

    • Figure China Erythropoietin (EPO) Sales Value Share by Region (2018-2023)

    • Table North China Erythropoietin (EPO) Production Volume by Type (2018-2023)

    • Table North China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Figure North China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Table North China Erythropoietin (EPO) Sales Volume by Application (2018-2023)

    • Table North China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Figure North China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Table Central China Erythropoietin (EPO) Production Volume by Type (2018-2023)

    • Table Central China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Figure Central China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Table Central China Erythropoietin (EPO) Sales Volume by Application (2018-2023)

    • Table Central China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Figure Central China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Table South China Erythropoietin (EPO) Production Volume by Type (2018-2023)

    • Table South China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Figure South China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Table South China Erythropoietin (EPO) Sales Volume by Application (2018-2023)

    • Table South China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Figure South China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Table East China Erythropoietin (EPO) Production Volume by Type (2018-2023)

    • Table East China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Figure East China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Table East China Erythropoietin (EPO) Sales Volume by Application (2018-2023)

    • Table East China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Figure East China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Erythropoietin (EPO) Production Volume by Type (2018-2023)

    • Table Northeast China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Table Northeast China Erythropoietin (EPO) Sales Volume by Application (2018-2023)

    • Table Northeast China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Erythropoietin (EPO) Production Volume by Type (2018-2023)

    • Table Southwest China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Table Southwest China Erythropoietin (EPO) Sales Volume by Application (2018-2023)

    • Table Southwest China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Erythropoietin (EPO) Production Volume by Type (2018-2023)

    • Table Northwest China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Erythropoietin (EPO) Production Volume Share by Type (2018-2023)

    • Table Northwest China Erythropoietin (EPO) Sales Volume by Application (2018-2023)

    • Table Northwest China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Erythropoietin (EPO) Sales Volume Share by Application (2018-2023)

    • Table LG Life Sciences Ltd Company Profile

    • Table LG Life Sciences Ltd Erythropoietin (EPO) Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Erythropoietin (EPO) Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Erythropoietin (EPO) Revenue, Price and Gross (2018-2023)

    • Table DRG International, Inc Company Profile

    • Table DRG International, Inc Erythropoietin (EPO) Revenue, Price and Gross (2018-2023)

    • Table Hospira Inc Company Profile

    • Table Hospira Inc Erythropoietin (EPO) Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Erythropoietin (EPO) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US